Mayo Risk Score (MRS) was used for the evaluation of patients with Primary biliary cirrhosis and primary sclerosing cholangitis which has been validated using independent data sets at different institutions15.
Milan's Criteria was used for hepatocellular carcinoma and Mayo risk scores (MRS) for patients with Primary Biliary Cirrhosis and Primary Sclerosing Cholangits.
Patients of primary biliary cirrhosis and primary sclerosing cholangits were evaluated on the basis of Mayo Risk Scores while in cases of hepatocellular carcinoma, patients meeting United Network for Organ Sharing (UNOS) criteria (1 lesion 2-5 cm or 2 to 3 lesions less than 3 cm) were considered eligible for priority listing.